validation of non-invasive ai diagnostic tool for mds
Published 1 year ago • 90 plays • Length 5:55Download video MP4
Download video MP3
Similar videos
-
2:48
validation of iwg 2023 criteria for response to treatment with hma in hr-mds
-
2:33
what can artificial intelligence bring to the diagnosis and management of mds?
-
3:57
validation of the ipss-m risk stratification system in mds
-
3:35
real-world validation of the value of the ipss-m for prognostication in patients with mds
-
1:51
factors driving the transformation of chip to mds
-
1:29
automated tool for mds classification using the who & icc classification systems
-
2:12
allosct for aml with mds-related features as per the icc and who 2022 classifications
-
2:12
barriers to the implementation and standardization of ai in the clinic
-
6:45
clonal hematopoiesis of indeterminate potential as a novel risk factor for stroke
-
1:06:29
an introduction into mitochondrial diseases in adulthood delivered by cornelia kornblum
-
50:56
chip and ccus, precursors to mds
-
3:22
performance of the aipss-mds ml model in predicting os & leukemic transformation in cmml
-
7:25
ai in hematology: advances, challenges, and future applications
-
9:41
the i4mds consortium and immune monitoring in mds
-
1:52
advances in lr-mds and hr-mds in 2023 and beyond
-
2:47
using artificial intelligence to estimate overall mortality and non-relapse mortality after allosct
-
1:17
using an ai model to quantify under-utilization of allosct for aml in the uk
-
6:05
the flipi24 model for identifying poor outcomes in non-immunochemotherapy treated fl
-
1:12
hypomethylating agents for low risk mds
-
59:39
validation of mri as a biomarker in clinical trials.
-
2:01
updates in mds diagnosis and prognosis with the ipss-m: personalized medicine in 2023